Daily news

Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.

« page 136

@RoxanaDaneshjou @arghavan_salles OMG – good to know that you are safe

in reply to RoxanaDaneshjou — 3:10pm Apr 11 2021 —

RT @AADmember: At the @US_FDA General and Plastic Surgery Devices Advisory Panel meeting, dermatologists shared perspectives on the risks a…

2:49pm Apr 11 2021 —

Millennials Turning to Telehealth, Online Research medscape.com/viewarticle/94… FYI ⁦@juleslipoff⁩

1:00pm Apr 10 2021 —

@Primary_Immune Thanks Yoni – very interesting

in reply to Primary_Immune — 12:57pm Apr 10 2021 —

RT @Primary_Immune: VEXAS syndrome:

…on this rare autoinflammatory disorder identified in 2020…
bit.ly/2OlUefl #immunology #g…

12:56pm Apr 10 2021 —

A mandated, nonmedical switch from adalimumab (Humira) to a biosimilar for psoriasis did not lead to a drop-off in…

https://twitter.com/i/web/status/1380940482533060608

12:47pm Apr 10 2021 —

@MedicalLetter @JAMADerm @JAMA_current @JAMA_current you mean « some topical corticosteroids to treat atopic dermat…

https://twitter.com/i/web/status/1380938271308578822

in reply to MedicalLetter — 12:38pm Apr 10 2021 —

RT @MedicalLetter: As seen in @JAMA_current – our table with key information about topical corticosteroids available to treat atopic dermat…

12:34pm Apr 10 2021 —

RT @JAMADerm: Topical timolol appears well tolerated in the treatment of early proliferative infantile hemangioma but provides limited bene…

12:34pm Apr 10 2021 —

La Peaulogie is an open access social & human sciences journal about #skin. lapeaulogie.fr/en/review/
This a call for…

https://twitter.com/i/web/status/1380563200538775557

11:48am Apr 9 2021 —